Retinal Degeneration - Potsdam Meeting der ProRetina Stiftung 2017

· Potsdam-Meeting

A look at cutting-edge translational research

Friday, April 7, 2017

  • 13:00-13:05 Welcome remarks Franz Badura, PRO RETINA FOUNDATION / RESEARCH DIVISION
  • 13:05-14:30 Session 1 – Selected Poster Presentations 8 abstracts to be selected
  • 14:30-15:00 Keynote Lecture Michael Brand, Dresden“Learning from the zebrafish: regeneration of the retina is possible – buthow does it work?“
  • 15:00-15:45 Coffee break
  • 15:45-17:25 Session 2 – Modifying disease processes
  • 15:45-16:10 Stephen H. Tsang, New York „Personalized therapeutic strategies for patients with retinitis pigmentosa“
  • 16:10-16:35 Sandro Banfi, Naples „The role of microRNAs in the human retina“
  • 16:35-17:00 Bernhard G. Herrmann, Berlin „Long non-coding RNA in development and disease“
  • 17:00-17:25 Francois Paquet-Durant, Tübingen „Targeting cGMP-signaling in inherited retinal degeneration“
  • 17:30 Dinner
  • 19:00-20:00 Session 3 – Of men and mice in science
  • 19:00-19:30 Eberhardt Zrenner, Tübingen „Hereditary retinal disorders: A pioneering field in biological research“
  • 19:30-20:00 Wolfgang Baehr, Salt Lake City „The rd mouse – a long story“
  • 20:00-open Swingin‘ Poster Session

Saturday, April 8, 2017

  • 09:00-10:40 Session 4 – „An update on disease mechanisms“
  • 09:00-09:25 Peter Zipfel, Jena „12 years after: The search for complement inhibitors in AMD“
  • 09:25-09:50 Florian Sennlaub Paris „Complement Factor H controls macrophage life-span“
  • 09:50-10:15 Tim Krohne, Bonn „The NLRP3 inflammasome – new therapeutic target in macular degeneration“
  • 10:15-10:40 Najate AIT-ALI, Paris „Mode of action of RdCVF and its origin“
  • 10:40-11:15 Coffee break
  • 11:15-12:55 Session 5 – „Innovative approaches to translation“
  • 11:15-11:40 Dr. Sebastian Bultmann, München „Visualization of specific DNA sequences in living mouse embryonic stem cells with a programmable fluorescent CRISPR/Cas system.
  • 11:40-12:05 Elly Tanaka, Wien Regeneration of complex multi-tissue structures
  • 12:05-12:30 Kathleen C. Keough, San Francisco „CRISPR/Cas9 Genome Surgery to Eliminate Dominant Negative Disease“
  • 12:30-12:55 Morgan Maeder, Cambridge Massachusetts „Envisioning a Gene Editing Approach to Treat Inherited Blindness“
  • 12:55-13:00 Concluding remarks
  • 13:00 Lunch and end of meeting

← Alle News